Clinician Link.AI ™️’s Post

🌟👁️ Discover the clinical advantages of high-dose EYLEA® HD (aflibercept) Injection HCP through the experiences of Drs. Kenneth Fan, Sherveen Salek, and David Brown. In a compelling series of interviews, these experts discuss the effectiveness of this treatment in managing severe retinal diseases, sharing their successes in transforming patient outcomes. Learn more about the potent impact of high-dose Eylea on ophthalmic care. #ASRS2024 #Ophthalmology #MedicalLeadership #VisionaryInOphthalmology #MedicalInnovation #RetinaSpecialists #EyeCareInnovation #VisionScience #MedTech #HealthcareTrends #ClinicalResearch ASRS – American Society of Retina Specialists Bayer Bayer | Ophthalmology

👁️💡 Dr. Sherveen Salek shares his positive experiences with EYLEA® HD (aflibercept) Injection HCP High Dose, a game-changer in retinal treatment. Having incorporated it into their formulary in recent months, Dr. Salek has seen remarkable results, especially in patients who previously required frequent injections. His insights highlight the potential for extending treatment intervals and enhancing patient outcomes with this advanced therapy. Join the discussion on the future of eye care and how these innovations are reshaping patient management. #ASRS2024 #Ophthalmology #MedicalLeadership #VisionaryInOphthalmology #MedicalInnovation #RetinaSpecialists #EyeCareInnovation #VisionScience #MedTech #HealthcareTrends #ClinicalResearch Bayer Bayer | Ophthalmology ASRS – American Society of Retina Specialists Saghar Bagheri MD PhD

🎥 Join Dr. John Kitchens (RETINA ASSOCIATES OF KENTUCKY) as he discusses the remarkable impact of Bayer | Ophthalmology aflibercept 8 mg in reducing the number of injections over two years. Discover how this advancement not only equates to cost neutrality compared to existing therapies but also offers significant benefits for the healthcare system by decreasing the frequency of examinations and imaging. Dive into the conversation to understand how aflibercept 8 mg is transforming patient care by offering less frequent treatments while maintaining effectiveness. #COPHY2024 #EyleaHD #AntiVEGF #OphthalmologyInnovation #Aflibercept8mg #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation  COPHy Congress Simrat Sodhi

How do you stay updated with the latest research findings in ophthalmology? Follow DJCRO on Instagram, X, and LinkedIn - stay in the know! 👀 Check out our latest case reports here: https://lnkd.in/eMKUiD6R Have a fun and safe holiday! #ophthalmology #medicine #research

🎥 Explore the new frontier in anti-VEGF therapies with Dr. John Kitchens (RETINA ASSOCIATES OF KENTUCKY) as he compares the newer generation, including faricimab and Bayer | Ophthalmology 8 mg aflibercept, to older medications. Discover how Bayer | Ophthalmology Eylea HD (8 mg aflibercept) is revolutionizing treatment, allowing for fewer injections and extended treatment intervals, providing significant benefits for patients. Dr. Kitchens delves into the advantages of these advancements and how they're enhancing patient care in ophthalmology. Join us to learn how these innovations are changing the game! #COPHY2024 #EyleaHD #AntiVEGF #OphthalmologyInnovation #Aflibercept8mg #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #Surgicalretina  COPHy Congress Simrat Sodhi

Ophthopedia Update:Clinical outcome measures in vision and eye care: Traditionally, clinical outcome assessments have focused on the patient’s perspective through patient-reported outcome assessments; however, given the complexity, integration, and interactions of various participants within the clinical ophthalmology setting, we propose that additional diverse clinical perspectives should be explored in order to fully appreciate the value of care provided to patients. In this review we introduce a framework by which clinical outcome assessments (COAs) can be organized. #Ophthalmology #Eye #Ophthotwitter

I'm excited to share my recent experience using the new Streamline Viscocanaloplasty System from New World Medical in combination with the iStent Infinite from Glaukos for glaucoma management. This innovative approach has been instrumental in decreasing intraocular pressure (IOP) and reducing the medication burden for our patients. In the procedure, the Streamline system injects viscoelastic into Schlemm's canal, enhancing aqueous outflow. The attached video vividly demonstrates this process, showing viscoelastic and blood refluxing out of an iStent ostium as the viscoelastic is introduced. This visual evidence underscores the efficacy of combining these technologies to improve patient outcomes. Embracing such advancements allows us to offer better care and improve the quality of life for those affected by glaucoma. I'm looking forward to continuing to explore and implement cutting-edge solutions in ophthalmology. #GlaucomaManagement #InterventionalGlaucoma #OphthalmologyInnovation #PatientCare #Glaukos #NewWorldMedical #eyeassociatesofsouthtexas #jtkavanaghmd #streamline #istentinfinite #synergy

🌐👁️ Dive into the future of patient care with Dr. Rufino Silva at European Society of Retina Specialists (EURETINA) 2024! Dr. Silva shares groundbreaking insights on leveraging OCT and mobile technology to enhance patient monitoring. From detecting subtle changes with apps at home to utilizing peripheral OCT in clinics, these innovations aim to reduce clinic visits while ensuring effective management of conditions like PCV. 📱🔍 Discover how these technologies not only ease the treatment burden but also improve the precision in monitoring disease progression. Dr. Silva highlights the efficacy of EYLEA® HD (aflibercept) Injection HCP 8mg in delivering both anatomical and functional improvements for patients. 🎥 Stay tuned as Dr. Silva elaborates on the integration of advanced biomarkers and technology in ophthalmology, paving the way for more personalized and efficient patient care. #Euretina #Ophthalmology #EyeCare #RetinaSpecialist #MedicalInnovation #VisionHealth #EyeHealth #DigitalHealth #Retina #Ophthalmology #ClinicianLinkLive  Bayer Bayer | Ophthalmology

Our Medical Advisor, Theodore Leng, MD, MS, will head to Sweden next week to present results from the FARETINA-DME Study at the ASRS Annual Meeting. The study analyzes #RWD from the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight) to identify the 12-month real-world clinical and anatomical outcomes with #faricimab in patients with diabetic macular edema. https://hubs.la/Q02G9Fcz0 #DME #rwd #rwe

The prevalence of #myopia is increasing, and our clinicians are witnessing a growing number of patients in need of #myopiamanagement or treatment due to this epidemic. By 2050, a projected 50% of the world's population will be myopic.* This tidal wave of myopia will drastically impact #optometrists and #ophthalmologists. For #MyopiaAwarenessWeek, let's discuss key strategies to combat this growing crisis: 🔍 Comprehensive eye exams with advanced ophthalmic equipment like slit lamps, ophthalmoscopes, and biometers can identify myopia signs early. 📏 Precise axial length capturing tools like Ultrasound A-Scan biometry provide quantifiable measurements to aid myopia management diagnosis monitoring and treatment plans. ⚖️ IOP monitoring for myopia-related changes tonometry is essential, as high myopes face greater glaucoma risk. This myopia awareness week, make myopia management a priority. At Keeler, we manufacture high quality diagnostic ophthalmological equipment in collaboration with clinicians to help you focus on giving the best outcomes for your patients. If you’d like to find out more about Keeler, drop a comment below and someone will be in touch. *AAO Journal, May 2016 American Academy of Ophthalmology #Keeler #Ophthalmology #Eyecare